• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血色素沉着症:遗传学与病理生理学

Hemochromatosis: genetics and pathophysiology.

作者信息

Beutler Ernest

机构信息

Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.

出版信息

Annu Rev Med. 2006;57:331-47. doi: 10.1146/annurev.med.57.121304.131310.

DOI:10.1146/annurev.med.57.121304.131310
PMID:16409153
Abstract

A number of genetic disorders can result in the accumulation of excess iron in the body. These causes of hereditary hemochromatosis include defects in genes encoding HFE, transferrin receptor 2, ferroportin, hepcidin, and hemojuvelin. Hepcidin, with its cognate receptor, ferroportin, has emerged as a central regulator of iron homeostasis; all of the known causes of hemochromatosis appear to prevent this system from functioning normally. The most common form of primary hemochromatosis is that caused by C282Y mutation of the HFE gene. This mutation is most prevalent among Northern Europeans. Although the frequency of the homozygous genotype is approximately 5 per 1000, the disease itself is quite rare because the clinical penetrance of the genotype is very low.

摘要

许多遗传性疾病可导致体内铁过量蓄积。遗传性血色素沉着症的这些病因包括编码HFE、转铁蛋白受体2、铁转运蛋白、铁调素和血色素沉着蛋白的基因缺陷。铁调素与其同源受体铁转运蛋白已成为铁稳态的核心调节因子;所有已知的血色素沉着症病因似乎都阻止了该系统正常运作。原发性血色素沉着症最常见的形式是由HFE基因的C282Y突变引起的。这种突变在北欧人群中最为普遍。尽管纯合基因型的频率约为每1000人中有5人,但由于该基因型的临床外显率非常低,所以这种疾病本身相当罕见。

相似文献

1
Hemochromatosis: genetics and pathophysiology.血色素沉着症:遗传学与病理生理学
Annu Rev Med. 2006;57:331-47. doi: 10.1146/annurev.med.57.121304.131310.
2
[Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].[经典HFE(1型)血色素沉着症的病理生理学与遗传学]
Presse Med. 2007 Sep;36(9 Pt 2):1271-7. doi: 10.1016/j.lpm.2007.03.038. Epub 2007 May 22.
3
[Non-HFE-related hereditary iron overload].[非HFE相关的遗传性铁过载]
Presse Med. 2007 Sep;36(9 Pt 2):1279-91. doi: 10.1016/j.lpm.2007.01.042. Epub 2007 May 30.
4
Non-HFE hemochromatosis.非HFE型血色素沉着症
Semin Liver Dis. 2005 Nov;25(4):450-60. doi: 10.1055/s-2005-923316.
5
New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis.通过对非HFE遗传性血色素沉着症的研究获得对铁稳态的新认识。
Best Pract Res Clin Haematol. 2005 Jun;18(2):235-50. doi: 10.1016/j.beha.2004.09.004.
6
Iron disorders of genetic origin: a changing world.遗传性铁代谢紊乱:一个不断变化的世界。
Trends Mol Med. 2011 Dec;17(12):707-13. doi: 10.1016/j.molmed.2011.07.004. Epub 2011 Aug 20.
7
Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele.HFE C282Y等位基因患者中血色病抑制素和血色素沉着症相关蛋白新突变的鉴定。
Blood Cells Mol Dis. 2004 Nov-Dec;33(3):338-43. doi: 10.1016/j.bcmd.2004.08.002.
8
Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.遗传性血色病的遗传学、基因检测和管理:从铁调素发现至今已有 15 年
Gastroenterology. 2015 Oct;149(5):1240-1251.e4. doi: 10.1053/j.gastro.2015.06.045. Epub 2015 Jul 9.
9
Non-HFE haemochromatosis.非HFE型血色素沉着症
World J Gastroenterol. 2007 Sep 21;13(35):4690-8. doi: 10.3748/wjg.v13.i35.4690.
10
The molecular pathogenesis of hereditary hemochromatosis.遗传性血色素沉着症的分子发病机制。
Semin Liver Dis. 2011 Aug;31(3):280-92. doi: 10.1055/s-0031-1286059. Epub 2011 Sep 7.

引用本文的文献

1
Cystic Fibrosis and Hemochromatosis Carriers May Be Prone to Glucagon-like Peptide-1 Agonist Pancreatitis: 3 Cases.囊性纤维化和血色素沉着症携带者可能易患胰高血糖素样肽-1激动剂所致胰腺炎:3例报告
JCEM Case Rep. 2025 May 15;3(7):luaf104. doi: 10.1210/jcemcr/luaf104. eCollection 2025 Jul.
2
Influence of Genetic Polymorphisms and Biochemical Biomarkers on Response to Nutritional Iron Supplementation and Performance in a Professional Football Team: A Pilot Longitudinal Study.基因多态性和生化生物标志物对职业足球队营养性铁补充反应及运动表现的影响:一项纵向试点研究
Nutrients. 2025 Apr 19;17(8):1379. doi: 10.3390/nu17081379.
3
Engineering Peptide Inhibitors of the HFE-Transferrin Receptor 1 Complex.
工程化 HFE-转铁蛋白受体 1 复合物的肽抑制剂。
Molecules. 2022 Oct 4;27(19):6581. doi: 10.3390/molecules27196581.
4
Cellular binding analysis of recombinant hybrid heteropolymer of camel hepcidin and human ferritin H chain. The unexpected human H-ferritin binding to J774 murine macrophage cells.重组骆驼抗菌肽和人转铁蛋白 H 链杂合多聚物的细胞结合分析。出人意料的是,人 H 转铁蛋白与 J774 鼠巨噬细胞结合。
Mol Biol Rep. 2020 Feb;47(2):1265-1273. doi: 10.1007/s11033-019-05234-3. Epub 2019 Dec 14.
5
Iron regulatory protein 2 is a suppressor of mutant p53 in tumorigenesis.铁调节蛋白 2 是肿瘤发生中突变型 p53 的抑制因子。
Oncogene. 2019 Aug;38(35):6256-6269. doi: 10.1038/s41388-019-0876-5. Epub 2019 Jul 22.
6
Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2.铁氧还蛋白还原酶通过铁调节蛋白 2 对 p53 依赖性肿瘤抑制至关重要。
Genes Dev. 2017 Jun 15;31(12):1243-1256. doi: 10.1101/gad.299388.117. Epub 2017 Jul 26.
7
"Pumping iron"-how macrophages handle iron at the systemic, microenvironmental, and cellular levels.“锻炼肌肉”——巨噬细胞在全身、微环境和细胞水平上如何处理铁。
Pflugers Arch. 2017 Apr;469(3-4):397-418. doi: 10.1007/s00424-017-1944-8. Epub 2017 Mar 1.
8
Haplotype Analysis of Hemochromatosis Gene Polymorphisms in Chronic Hepatitis C Virus Infection: A Case Control Study.慢性丙型肝炎病毒感染中铁代谢紊乱基因多态性的单倍型分析:一项病例对照研究。
Iran Red Crescent Med J. 2016 May 15;18(6):e24675. doi: 10.5812/ircmj.24675. eCollection 2016 Jun.
9
Hepcidin Plays a Key Role in 6-OHDA Induced Iron Overload and Apoptotic Cell Death in a Cell Culture Model of Parkinson's Disease.在帕金森病细胞培养模型中,铁调素在6-羟基多巴胺诱导的铁过载和凋亡性细胞死亡中起关键作用。
Parkinsons Dis. 2016;2016:8684130. doi: 10.1155/2016/8684130. Epub 2016 May 19.
10
The evolutionary adaptation of the C282Y mutation to culture and climate during the European Neolithic.欧洲新石器时代C282Y突变对文化和气候的进化适应。
Am J Phys Anthropol. 2016 May;160(1):86-101. doi: 10.1002/ajpa.22937. Epub 2016 Jan 22.